Effects of Elaeagnus angustifolia L. supplementation on serum levels of inflammatory cytokines and matrix metalloproteinases in females with knee osteoarthritis

Complementary Therapies in Medicine

Volumn 22, Issue 5, 2014, Pages 864-869

  Nikniaz, Zeinab ^a   Ostadrahimi, Alireza ^b   Mahdavi, Reza ^c   Ebrahimi, Ali asghar ^d   Nikniaz, Leila ^e  

^a TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^b TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^c TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^d TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

^e TABRIZ UNIVERSITY OF MEDICAL SCIENCES   (Iran)

Author keywords

Cytokines; E. angistifolia L.; Inflammation; Osteoarthritis

Indexed keywords

COLLAGENASE 3; CYTOKINE; HERBACEOUS AGENT; INTERLEUKIN 10; INTERLEUKIN 1BETA; INTERSTITIAL COLLAGENASE; MATRIX METALLOPROTEINASE; PLACEBO; TUMOR NECROSIS FACTOR ALPHA; PLANT EXTRACT;

ADULT; AGED; ANTIINFLAMMATORY ACTIVITY; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; DISEASE SEVERITY; DOUBLE BLIND PROCEDURE; ELAEAGNUS ANGUSTIFOLIA; ELISA KIT; FEMALE; FRUIT; HUMAN; KNEE OSTEOARTHRITIS; MEDICINAL PLANT; POWDER; PROTEIN BLOOD LEVEL; RANDOMIZED CONTROLLED TRIAL; STATISTICAL ANALYSIS; SUPPLEMENTATION; BLOOD; CHEMISTRY; ELAEAGNACEAE; ENZYMOLOGY; MIDDLE AGED; OSTEOARTHRITIS, KNEE;

ADULT; AGED; CYTOKINES; ELAEAGNACEAE; FEMALE; FRUIT; HUMANS; MATRIX METALLOPROTEINASES; MIDDLE AGED; OSTEOARTHRITIS, KNEE; PLANT EXTRACTS;

EID: 84908150760     PISSN: 09652299     EISSN: 18736963     Source Type: Journal    
DOI: 10.1016/j.ctim.2014.07.004     Document Type: Article

References (26)

1. Salaffi F., De Angelis R., Stancati A., Grassi W., Arche Pain M. Health-related quality of life in multiple musculoskeletal conditions: a cross-sectional population based epidemiological study. II. The MAPPING study. Clin Exp Rheumatol 2005, 23:829-839. Prevalence Investigation Group (MAPPING) study.
2. Fernandes J.C., Martel-Pelletier J., Pelletier J.P. The role of cytokines in osteoarthritis pathophysiology. Biorheology 2002, 39:237-246.
3. Westacott C.I., Sharif M.C. Cytokines in osteoarthritis: mediators or markers of joint destruction?. Semin Arthritis Rheum 1996, 25:254-272.
4. Sondergaard B.C., Henriksen K., Wulf H., Oestergaard S., Schurigt U., Bräuer R., et al. Relative contribution of matrix metalloprotease and cysteine protease activities to cytokine-stimulated articular cartilage degradation. Osteoarthr Cartil 2006, 14:738-748.
5. Cauwe B., Van den Steen P.E., Opedenakker G. The biochemical, biological, and pathological kaleidoscope of cell surface substrates processed by matrix metalloproteinases. Crit Rev Biochem Mol Biol 2007, 42:113-185.
6. Hedbom E., Häuselmann H.J. Molecular aspects of pathogenesis in osteoarthritis: the role of inflammation. Cell Mol Life Sci 2002, 59:45-53.
7. Silverstein F.E., Faich G., Goldstein J.L., Simon L.S., Pincus T., Whelton A., et al. Gastrointestinal toxicity with celecoxib vs. nonsteroidal anti-inflammatory drugs for osteoarthritis and rheumatoid arthritis: the CLASS study: a randomized controlled trial. J Am Med Assoc 2002, 284:1247-1255.
8. Schmid B., Ludtke R., Selbmann H.K., Kötter I., Tschirdewahn B., Schaffner W., et al. Efficacy and tolerability of a standardized willow bark extract in patients with osteoarthritis: randomized placebo-controlled, double blind clinical trial. Phytother Res 2001, 15:344-350.
9. Medicinal plants 1990, Tehran University Press, Tehran. A. Zargari (Ed.).
10. Ahmadiani a., Hosseiny J., Semnanian S., Javan M., Saeedi F., Kamalinejad M., et al. Antinociceptive and anti-inflammatory effects of Elaeagnus angustifolia fruit extract. J Ethnopharmacol 2000, 72:287-292.
11. Hulejova H., Barešová V., Klézl Z., Polanska M., Adam M., Šenolt L. Increased level of cytokines and matrix metalloproteinases in osteoarthritic subchondral bone. Cytokine 2007, 38:151-156.
12. Fernández-Moreno M., Soto-Hermida A., Oreiro N., Pértega S., Fenández-López C., Rego-Pérez I., et al. Mitochondrial haplogroups define two phenotypes of osteoarthritis. Front Physiol 2012, 11(3):129.
13. Manicourt D.H., Azria M., Mindeholm L., Thonar E.J., Devogelaer J.P. Oral salmon calcitonin reduces Lequesne's algofunctional index scores and decreases urinary and serum levels of biomarkers of joint metabolism in knee osteoarthritis. Arthritis Rheumatol 2006, 54(10):3205-3211.
14. Farahbakhsh S., Arbabian S., Emami F., Rastegar Moghadam B., Ghoshooni H., Noroozzadeh A., et al. Inhibition of cyclooxygenase type 1 and 2 enzyme by aqueous extract of Elaeagnus angustifolia in mice. Basic Clin Neurosci 2011, 2(2):31-37.
15. Smith W.L., Garavito R.M., DeWitt D.L. Prostaglandin endoperoxide H synthase (cyclooxygenases-1 and -2). J Biol Chem 1996, 271:33157-33160.
16. Murakami M., Naraba H., Tanioka T., Semmya N., Nakatani Y., Kojima F., et al. Regulation of prostaglandin E2 biosynthesis by inducible membrane-associated prostaglandin E2 synthase that acts in concert with cyclooxygenase-2. J Biol Chem 2000, 275:32783-32792.
17. Bensen W.G., Fiechtner J.J., McMillen J.I., Zhao W.W., Yu S.S., Woods E.M., et al. Treatment of osteoarthritis with celecoxib, a cyclooxygenase-2 inhibitor: a randomized control trial. Mayo Clin Proc 1999, 74:1095-10105.
18. Bucur L., Vlase L., Istudor V., Popescu A. HPLC-MS analysis of the polyphenols in two soft extracts of Elaeagnus angustifolia L. Note 2. Soft extract of young branches analysis. Farmacia 2009, 57(6):736-742.
19. Ayaz F.A., Bertoft E. Sugar and phenolic acid composition of stored commercial oleaster fruits. J Food Compos Anal 2001, 14:505-511.
20. Wang Y., Guo T., Li J., Zhou S., Zhao P., Fan M. Four flavonoid glycosides from the pulps of Elaeagnus angustifolia and their antioxidant activities. Adv Mater Res 2013, 756-9:16-20.
21. Welton A.F., Tobias L.D., Fiedler-Nagy C., Anderson W., Hope W., Meyers K., et al. Effect of flavonoids on arachidonic acid metabolism. Plant flavonoids in biology and medicine 1986, 231-242. Alan R. Liss, New York. V. Cody, E. Middleton, J.B. Harborne (Eds.).
22. Noreen Y., Serrano G., Perera P., Bohlin L. Flavan-3-ols isolated from some medicinal plants inhibiting COX-1 and COX-2 catalysed prostaglandin biosynthesis. Planta Med 1998, 64:520-524.
23. Nikolaeva A.G. Alkaloids of Elaeagnus angustifolia. Chem Nat Compd 1970, 6(5):659.
24. Yamazaki Y., Kawano Y. Inhibitory effects of herbal alkaloids on the tumor necrosis factor-α and nitric oxide production in lipopolysaccharide-stimulated RAW264 macrophages. Chem Pharm Bull (Tokyo) 2011, 59(3):388-391.
25. Hara E.S., Ono M., Kubota S., Sonoyama W., Oida Y., Hattori T., et al. Novel chondrogenic and chondroprotective effects of the natural compound harmine. Biochemie 2013, 95(2):374-381.
26. Ahmed S., Wang N., Lalonde M., Goldberg V.M., Haqqi T.M. Green tea polyphenol epigallocatechin-3-gallate (EGCG) differentially inhibits interleukin-1β-induced expression of matrix metalloproteinase-1 and -13 in human chondrocytes. J Pharmacol Exp Ther 2004, 308(2):767-773.